Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cryo Cell International (CCEL) Assets: 2010-2025

Historic Assets for Cryo Cell International (CCEL) over the last 16 years, with Q3 2025 value amounting to $63.2 million.

  • Cryo Cell International's Assets rose 37.29% to $63.2 million in Q3 2025 from the same period last year, while for Aug 2025 it was $256.7 million, marking a year-over-year increase of 189.62%. This contributed to the annual value of $64.7 million for FY2024, which is 0.0% changed from last year.
  • As of Q3 2025, Cryo Cell International's Assets stood at $63.2 million, which was up 37.29% from $64.4 million recorded in Q2 2025.
  • In the past 5 years, Cryo Cell International's Assets registered a high of $105.3 million during Q1 2021, and its lowest value of $50.2 million during Q2 2021.
  • Its 5-year average for Assets is $64.8 million, with a median of $64.4 million in 2025.
  • In the last 5 years, Cryo Cell International's Assets skyrocketed by 13533.07% in 2021 and then tumbled by 4793.28% in 2022.
  • Cryo Cell International's Assets (Quarter) stood at $60.7 million in 2021, then rose by 6.97% to $64.9 million in 2022, then dropped by 0.32% to $64.7 million in 2023, then changed by 0.0% to $64.7 million in 2024, then dropped by 2.33% to $63.2 million in 2025.
  • Its Assets was $63.2 million in Q3 2025, compared to $64.4 million in Q2 2025 and $64.4 million in Q1 2025.